Author

Mohamed Attauabi

COMPARATIVE EFFICACY OF ADVANCED THERAPIES FOR FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
COMPARATIVE EFFICACY OF ADVANCED THERAPIES FOR FISTULIZING CROHN’S DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Mohamed Attauabi  et al.

PATIENTS WITH ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES DO NOT DIFFER FROM THOSE WITH ADULT-ONSET IN THEIR INITIAL PRESENTATION - FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)
PATIENTS WITH ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES DO NOT DIFFER FROM THOSE WITH ADULT-ONSET IN THEIR INITIAL PRESENTATION - FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)

Mohamed Attauabi  et al.

SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE
SYSTEMATIC REVIEW AND META-ANALYSIS: THE IMPACT OF CONCOMITANT IMMUNE-MEDIATED DISEASES ON THE DISEASE LOCALIZATION AND BEHAVIOUR IN PATIENTS WITH CROHN'S DISEASE

Mohamed Attauabi  et al.

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY
OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

Mohamed Attauabi  et al.

PREDICTORS OF AN EARLY SEVERE DISEASE COURSE OF NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES- FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)
PREDICTORS OF AN EARLY SEVERE DISEASE COURSE OF NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES- FINDINGS FROM A DANISH POPULATION-BASED INCEPTION COHORT (IBD PROGNOSIS STUDY)

Mohamed Attauabi  et al.

VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Mohamed Attauabi  et al.

VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
VEDOLIZUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN ELDERLY PATIENTS AND THOSE WITH CONTRAINDICATIONS FOR ANTI-TNF THERAPY: A REAL-WORLD, NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES

A POPULATION-BASED STUDY ON COVID-19 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES: PRELIMINARY RESULTS FROM THE DANISH COVID-IBD DATABASE
A POPULATION-BASED STUDY ON COVID-19 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES: PRELIMINARY RESULTS FROM THE DANISH COVID-IBD DATABASE

Mohamed Attauabi  et al.

COVID-19 AND INFLAMMATORY BOWEL DISEASE: PREVALENCE, RELATIONSHIP WITH IMMUNOSUPPRESSIVE THERAPIES AND MENTAL WELL-BEING. A NATIONWIDE DANISH SURVEY
COVID-19 AND INFLAMMATORY BOWEL DISEASE: PREVALENCE, RELATIONSHIP WITH IMMUNOSUPPRESSIVE THERAPIES AND MENTAL WELL-BEING. A NATIONWIDE DANISH SURVEY

Mohamed Attauabi  et al.

SHOULD ALL PATIENTS WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES BE SCREENED FOR METABOLIC BONE DISEASE? RESULTS FROM A DANISH POPULATION-BASED INCEPTION COHORT STUDY
SHOULD ALL PATIENTS WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASES BE SCREENED FOR METABOLIC BONE DISEASE? RESULTS FROM A DANISH POPULATION-BASED INCEPTION COHORT STUDY

Mohamed Attauabi  et al.

EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE
EFFICACY OF USTEKINUMAB FOR ACTIVE PERIANAL FISTULIZING CROHN'S DISEASE: A DOUBLE CENTER COHORT STUDY AND A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE CURRENT LITERATURE

Mohamed Attauabi  et al.

OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY
OUTCOMES OF CORONAVIRUS DISEASE 2019 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES AND THE INFLUENCE OF IBD-RELATED MEDICATIONS– A DANISH PROSPECTIVE POPULATION-BASED COHORT STUDY

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN BIO-NAïVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE - AN INTERIM ANALYSIS FROM A DANISH NATIONAL COHORT STUDY

Mohamed Attauabi  et al.

THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE
THE REAL-WORLD EFFICACY AND SAFETY OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES - A DOUBLE-CENTER DANISH EXPERIENCE

Mohamed Attauabi  et al.

TIME TO EFFECT OF BIOLOGICS AND SMALL MOLECULES IN MODERATELY TO SEVERELY ACTIVE LUMINAL CROHN’S DISEASE – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
TIME TO EFFECT OF BIOLOGICS AND SMALL MOLECULES IN MODERATELY TO SEVERELY ACTIVE LUMINAL CROHN’S DISEASE – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Mohamed Attauabi  et al.

INTESTINAL ULTRASOUND AT IBD DIAGNOSIS PREDICTS MAJOR DISEASE EVENTS – A COPENHAGEN IBD COHORT STUDY
INTESTINAL ULTRASOUND AT IBD DIAGNOSIS PREDICTS MAJOR DISEASE EVENTS – A COPENHAGEN IBD COHORT STUDY

Mohamed Attauabi  et al.

INTESTINAL ULTRASOUND IS RESPONSIVE TO TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE
INTESTINAL ULTRASOUND IS RESPONSIVE TO TREATMENT IN NEWLY DIAGNOSED CROHN’S DISEASE

Mohamed Attauabi  et al.

PERIPHERAL JOINT AND ENTHESIS INVOLVEMENT IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): SYMPTOMS, CLINICAL AND ULTRASONOGRAPHIC FINDINGS
PERIPHERAL JOINT AND ENTHESIS INVOLVEMENT IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): SYMPTOMS, CLINICAL AND ULTRASONOGRAPHIC FINDINGS

Mohamed Attauabi  et al.

OUTCOMES OF FIRST-LINE BIOLOGICALS IN A MULTICENTER PROSPECTIVE COHORT OF BIOLOGICAL-NAÏVE IBD PATIENTS – THE DANISH IBD BIOBANK PROJECT
OUTCOMES OF FIRST-LINE BIOLOGICALS IN A MULTICENTER PROSPECTIVE COHORT OF BIOLOGICAL-NAÏVE IBD PATIENTS – THE DANISH IBD BIOBANK PROJECT

Mohamed Attauabi  et al.

Item 1 - 19 / 19
1